{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:38Z","timestamp":1793851478341,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/ncprheum0221","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T22:47:10Z","timestamp":1152226030000},"page":"364-372","source":"Crossref","is-referenced-by-count":60,"title":["Therapy Insight: fibromyalgia\u2014a different type of pain needing a different type of treatment"],"prefix":"10.1038","volume":"2","author":[{"given":"Dina","family":"Dadabhoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Clauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncprheum0221_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F  et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160\u2013172","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR2","first-page":"151","volume":"22","author":"F Wolfe","year":"1995","unstructured":"Wolfe F  et al. (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22: 151\u2013156","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR3","first-page":"710","volume":"20","author":"P Croft","year":"1993","unstructured":"Croft P  et al. (1993) The prevalence of chronic widespread pain in the general population. J Rheumatol 20: 710\u2013713","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.1780380104","volume":"38","author":"F Wolfe","year":"1995","unstructured":"Wolfe F  et al. (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19\u201328","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/bmj.309.6956.696","volume":"309","author":"P Croft","year":"1994","unstructured":"Croft P  et al. (1994) Population study of tender point counts and pain as evidence of fibromyalgia. Br Med J 309: 696\u2013699","journal-title":"Br Med J"},{"key":"BFncprheum0221_CR6","first-page":"2568","volume":"28","author":"F Petzke","year":"2001","unstructured":"Petzke F  et al. (2001) Dolorimetry performed at 3 paired tender points highly predicts overall tenderness. J Rheumatol 28: 2568\u20132569","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/art.1780360510","volume":"36","author":"G Granges","year":"1993","unstructured":"Granges G and Littlejohn G (1993) Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36: 642\u2013646","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/ard.56.4.268","volume":"56","author":"F Wolfe","year":"1997","unstructured":"Wolfe F (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56: 268\u2013271","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0221_CR9","first-page":"S342","volume":"42","author":"F Petzke","year":"1999","unstructured":"Petzke F  et al. (1999) Pain sensitivity in patients with fibromyalgia (FM): Expectancy effects on pain measurements. Arthritis Rheum 42: S342","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/ard.55.7.482","volume":"55","author":"P Croft","year":"1996","unstructured":"Croft P  et al. (1996) More pain, more tender points: is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis 55: 482\u2013485","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0221_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/ard.61.12.1071","volume":"61","author":"AC Papageorgiou","year":"2002","unstructured":"Papageorgiou AC  et al. (2002) Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 61: 1071\u20131074","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0221_CR12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/art.20042","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM  et al. (2004) Family study of fibromyalgia. Arthritis Rheum 50: 944\u2013952","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/nbdi.1999.0262","volume":"6","author":"B Bondy","year":"1999","unstructured":"Bondy B  et al. (1999) The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 6: 433\u2013439","journal-title":"Neurobiol Dis"},{"key":"BFncprheum0221_CR14","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B","volume":"42","author":"M Offenbaecher","year":"1999","unstructured":"Offenbaecher M  et al. (1999) Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42: 2482\u20132488","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/sj.mp.4001568","volume":"9","author":"D Buskila","year":"2004","unstructured":"Buskila D  et al. (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9: 730\u2013731","journal-title":"Mol Psychiatry"},{"key":"BFncprheum0221_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000097332","volume":"4","author":"DJ Clauw","year":"1997","unstructured":"Clauw DJ and Chrousos GP (1997) Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4: 134\u2013153","journal-title":"Neuroimmunomodulation"},{"key":"BFncprheum0221_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.1780371105","volume":"37","author":"LJ Crofford","year":"1994","unstructured":"Crofford LJ  et al. (1994) Hypothalamic\u2013pituitary\u2013adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37: 1583\u20131592","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1749-6632.1998.tb09607.x","volume":"840","author":"MA Demitrack","year":"1998","unstructured":"Demitrack MA and Crofford LJ (1998) Evidence for and pathophysiologic implications of hypothalamic\u2013pituitary\u2013adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann NY Acad Sci 840: 684\u2013697","journal-title":"Ann NY Acad Sci"},{"key":"BFncprheum0221_CR19","first-page":"1383","volume":"18","author":"ZG Qiao","year":"1991","unstructured":"Qiao ZG  et al. (1991) Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 18: 1383\u20131389","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0002-9343(99)00074-1","volume":"106","author":"GK Adler","year":"1999","unstructured":"Adler GK  et al. (1999) Reduced hypothalamic\u2013pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106: 534\u2013543","journal-title":"Am J Med"},{"key":"BFncprheum0221_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/1529-0131(199811)41:11<1966::AID-ART11>3.0.CO;2-O","volume":"41","author":"M Martinez-Lavin","year":"1998","unstructured":"Martinez-Lavin M  et al. (1998) Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 41: 1966\u20131971","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR22","doi-asserted-by":"publisher","first-page":"R992","DOI":"10.1186\/ar1772","volume":"7","author":"J McBeth","year":"2005","unstructured":"McBeth J  et al. (2005) Hypothalamic\u2013pituitary\u2013adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther 7: R992\u2013R1000","journal-title":"Arthritis Res Ther"},{"key":"BFncprheum0221_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0022-3999(04)00080-7","volume":"57","author":"JM Glass","year":"2004","unstructured":"Glass JM  et al. (2004) The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res 57: 391\u2013398","journal-title":"J Psychosom Res"},{"key":"BFncprheum0221_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(94)90046-9","volume":"59","author":"S Lautenbacher","year":"1994","unstructured":"Lautenbacher S  et al. (1994) Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59: 45\u201353","journal-title":"Pain"},{"key":"BFncprheum0221_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/art.10225","volume":"46","author":"RH Gracely","year":"2002","unstructured":"Gracely RH  et al. (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46: 1333\u20131343","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR26","first-page":"22","volume":"75","author":"DD Price","year":"2005","unstructured":"Price DD and Staud R (2005) Neurobiology of fibromyalgia syndrome. J Rheumatol Suppl 75: 22\u201328","journal-title":"J Rheumatol Suppl"},{"key":"BFncprheum0221_CR27","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/art.1780371106","volume":"37","author":"IJ Russell","year":"1994","unstructured":"Russell IJ  et al. (1994) Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37: 1593\u20131601","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1212\/WNL.57.1.132","volume":"57","author":"P Sarchielli","year":"2001","unstructured":"Sarchielli P  et al. (2001) Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 57: 132\u2013134","journal-title":"Neurology"},{"key":"BFncprheum0221_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1302\/0301-620X.84B6.12738","volume":"84","author":"EK Alpar","year":"2002","unstructured":"Alpar EK  et al. (2002) Management of chronic pain in whiplash injury. J Bone Joint Surg Br 84: 807\u2013811","journal-title":"J Bone Joint Surg Br"},{"key":"BFncprheum0221_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000087656","volume":"14","author":"R Suzuki","year":"2005","unstructured":"Suzuki R and Dickenson A (2005) Spinal and suparaspinal contributions to central sensitization in peripheral neuropathy. Neurosignals 14: 175\u2013181","journal-title":"Neurosignals"},{"key":"BFncprheum0221_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0304-3959(96)03188-0","volume":"68","author":"E Kosek","year":"1996","unstructured":"Kosek E  et al. (1996) Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68: 375\u2013383","journal-title":"Pain"},{"key":"BFncprheum0221_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","volume":"114","author":"N Julien","year":"2005","unstructured":"Julien N  et al. (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114: 295\u2013302","journal-title":"Pain"},{"key":"BFncprheum0221_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2474-5-48","volume":"5","author":"JN Baraniuk","year":"2004","unstructured":"Baraniuk JN  et al. (2004) Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5: 48","journal-title":"BMC Musculoskelet Disord"},{"key":"BFncprheum0221_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/art.1780350509","volume":"35","author":"IJ Russell","year":"1992","unstructured":"Russell IJ  et al. (1992) Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35: 550\u2013556","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR35","first-page":"90","volume":"19","author":"MB Yunus","year":"1992","unstructured":"Yunus MB  et al. (1992) Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 19: 90\u201394","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR36","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1097\/00007632-199610150-00021","volume":"21","author":"NM Hadler","year":"1996","unstructured":"Hadler NM (1996) If you have to prove you are ill, you can't get well. The object lesson of fibromyalgia. Spine 21: 2397\u20132400","journal-title":"Spine"},{"key":"BFncprheum0221_CR37","first-page":"1552","volume":"18","author":"DJ Hawley","year":"1991","unstructured":"Hawley DJ and Wolfe F (1991) Pain, disability, and pain\/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol 18: 1552\u20131557","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/anr.1790020406","volume":"2","author":"LF Callahan","year":"1989","unstructured":"Callahan LF  et al. (1989) Self-report questionnaires in five rheumatic diseases: comparisons of health status constructs and associations with formal education level. Arthritis Care Res 2: 122\u2013131","journal-title":"Arthritis Care Res"},{"key":"BFncprheum0221_CR39","first-page":"1255","volume":"23","author":"DC Turk","year":"1996","unstructured":"Turk DC  et al. (1996) Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol 23: 1255\u20131262","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR40","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1002\/art.11272","volume":"48","author":"T Giesecke","year":"2003","unstructured":"Giesecke T  et al. (2003) Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 48: 2916\u20132922","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR41","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/art.21008","volume":"52","author":"T Giesecke","year":"2005","unstructured":"Giesecke T  et al. (2005) The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 52: 1577\u20131584","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/brain\/awh098","volume":"127","author":"RH Gracely","year":"2004","unstructured":"Gracely RH  et al. (2004) Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127: 835\u2013843","journal-title":"Brain"},{"key":"BFncprheum0221_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0304-3959(00)00259-1","volume":"86","author":"ML Peters","year":"2000","unstructured":"Peters ML  et al. (2000) Do fibromyalgia patients display hypervigilance for innocuous somatosensory stimuli? Application of a body scanning reaction time paradigm. Pain 86: 283\u2013292","journal-title":"Pain"},{"key":"BFncprheum0221_CR44","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.292.19.2388","volume":"292","author":"DL Goldenberg","year":"2004","unstructured":"Goldenberg DL  et al. (2004) Management of fibromyalgia syndrome. JAMA 292: 2388\u20132395","journal-title":"JAMA"},{"key":"BFncprheum0221_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/art.10400","volume":"47","author":"KP White","year":"2002","unstructured":"White KP  et al. (2002) Does the label \u201cfibromyalgia\u201d alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 47: 260\u2013265","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1176\/appi.psy.41.2.104","volume":"41","author":"LM Arnold","year":"2000","unstructured":"Arnold LM  et al. (2000) Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41: 104\u2013113","journal-title":"Psychosomatics"},{"key":"BFncprheum0221_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1163\/156856902320761423","volume":"14","author":"K Capaci","year":"2002","unstructured":"Capaci K and Hepguler S (2002) Comparison of the effects of amitriptyline and paroxetine in the treatment of fibromyalgia syndrome. Pain Clinic 14: 223\u2013228","journal-title":"Pain Clinic"},{"key":"BFncprheum0221_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/eujp.1999.0148","volume":"4","author":"UM Anderberg","year":"2000","unstructured":"Anderberg UM  et al. (2000) Citalopram in patients with fibromyalgia\u2014a randomized, double-blind, placebo-controlled study. European Journal of Pain 4: 27\u201335","journal-title":"European Journal of Pain"},{"key":"BFncprheum0221_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0304-3959(94)00218-4","volume":"61","author":"J Norregaard","year":"1995","unstructured":"Norregaard J  et al. (1995) A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 61: 445\u2013449","journal-title":"Pain"},{"key":"BFncprheum0221_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/07853890008995932","volume":"32","author":"D Fishbain","year":"2000","unstructured":"Fishbain D (2000) Evidence-based data on pain relief with antidepressants. Ann Med 32: 305\u2013316","journal-title":"Ann Med"},{"key":"BFncprheum0221_CR51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1526-4610.2000.00089.x","volume":"40","author":"LC Adelman","year":"2000","unstructured":"Adelman LC  et al. (2000) Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 40: 572\u2013580","journal-title":"Headache"},{"key":"BFncprheum0221_CR52","first-page":"1975","volume":"32","author":"RM Gendreau","year":"2005","unstructured":"Gendreau RM  et al. (2005) Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 32: 1975\u20131985","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR53","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM  et al. (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50: 2974\u20132984","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR54","first-page":"1","volume":"21","author":"L Farber","year":"2001","unstructured":"Farber L  et al. (2001) Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Int J Clin Pharmacol Res 21: 1\u201313","journal-title":"Int J Clin Pharmacol Res"},{"key":"BFncprheum0221_CR55","doi-asserted-by":"crossref","unstructured":"Wiffen P  et al. (2000) Anticonvulsant drugs for acute and chronic pain. The Cochrane Database Of Systematic Reviews, Issue 3, Art. No CD001133","DOI":"10.1002\/14651858.CD001133"},{"key":"BFncprheum0221_CR56","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/art.20983","volume":"52","author":"LJ Crofford","year":"2005","unstructured":"Crofford LJ  et al. (2005) Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52: 1264\u20131273","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1526-4610.2000.00014.x","volume":"40","author":"C Redillas","year":"2000","unstructured":"Redillas C and Solomon S (2000) Prophylactic pharmacological treatment of chronic daily headache. Headache 40: 83\u2013102","journal-title":"Headache"},{"key":"BFncprheum0221_CR58","first-page":"1070","volume":"30","author":"MB Scharf","year":"2003","unstructured":"Scharf MB  et al. (2003) The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 30: 1070\u20131074","journal-title":"J Rheumatol"},{"key":"BFncprheum0221_CR59","first-page":"79","volume":"1","author":"RM Bennett","year":"2001","unstructured":"Bennett RM (2001) Pharmacological treatment of fibromyalgia. J Funct Syndr 1: 79\u201392","journal-title":"J Funct Syndr"},{"key":"BFncprheum0221_CR60","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.21191","volume":"52","author":"AJ Holman","year":"2005","unstructured":"Holman AJ and Myers RR (2005) A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52: 2495\u20132505","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR61","doi-asserted-by":"publisher","first-page":"S614","DOI":"10.1002\/art.10141","volume":"46","author":"IJ Russell","year":"2002","unstructured":"Russell IJ  et al. (2002) Therapy with a central alpha 2-adrenergic agonist (tizanidine) decreases cerebrospinal fluid substance P, and may reduce serum hyaluronic acid as it improves the clinical symptoms of the fibromyalgia syndrome. Arthritis Rheum 46: S614","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0221_CR62","first-page":"S210","volume":"43","author":"DA Williams","year":"2000","unstructured":"Williams DA  et al. (2000) Randomized controlled trial of CBT to improve functional status in fibromyalgia. Am College Rheumatol 43: S210","journal-title":"Am College Rheumatol"},{"key":"BFncprheum0221_CR63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1089\/acm.2005.11.663","volume":"11","author":"RE Harris","year":"2005","unstructured":"Harris RE  et al. (2005) Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequency. J Altern Complement Med 11: 663\u2013671","journal-title":"J Altern Complement Med"},{"key":"BFncprheum0221_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-143-1-200507050-00005","volume":"143","author":"NP Assefi","year":"2005","unstructured":"Assefi NP  et al. (2005) A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med 143: 10\u201319","journal-title":"Ann Intern Med"},{"key":"BFncprheum0221_CR65","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7326\/0003-4819-142-11-200506070-00005","volume":"142","author":"S Eisen","year":"2005","unstructured":"Eisen S  et al. (2005) Gulf War veterans' health: medical evaluation of a U.S. cohort. Ann Intern Med 142: 881\u2013890","journal-title":"Ann Intern Med"},{"key":"BFncprheum0221_CR66","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/aje\/155.11.1033","volume":"155","author":"G Gray","year":"2002","unstructured":"Gray G  et al. (2002) Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol 155: 1033\u20131044","journal-title":"Am J Epidemiol"},{"key":"BFncprheum0221_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/archinte.160.2.221","volume":"160","author":"LA Aaron","year":"2000","unstructured":"Aaron LA  et al. (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160: 221\u2013227","journal-title":"Arch Intern Med"},{"key":"BFncprheum0221_CR68","doi-asserted-by":"publisher","first-page":"868","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00011","volume":"134","author":"LA Aaron","year":"2001","unstructured":"Aaron LA and Buchwald D (2001) A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134: 868\u2013881","journal-title":"Ann Intern Med"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0221","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:59:05Z","timestamp":1684443545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["BFncprheum0221"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0221","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}